Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations

Europace

Volumn 16, Issue 7, 2014, Pages 1028-1032

  Kosiuk, Jedrzej ^a   Koutalas, Emmanuel ^a   Doering, Michael ^a   Sommer, Philipp ^a   Rolf, Sascha ^a   Breithardt, Ole A ^a   Nedios, Sotirios ^a   Dinov, Borislav ^a   Hindricks, Gerhard ^a   Richter, Sergio ^a   Bollmann, Andreas ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Dabigatran; Implantable cardioverter defibrillator; Pacemaker; Rivaroxaban

Indexed keywords

ANTICOAGULANT AGENT; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; DABIGATRAN; MORPHOLINE DERIVATIVE; RIVAROXABAN; THIOPHENE DERIVATIVE;

ARTICLE; PRIORITY JOURNAL; AGED; ANALOGS AND DERIVATIVES; ARTIFICIAL HEART PACEMAKER; ATRIAL FIBRILLATION; CARDIOVERSION; CHEMICALLY INDUCED; COMPARATIVE STUDY; FEMALE; GERMANY; HEART PACING; HEMATOMA; HEMORRHAGE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROSTHESIS; PROSTHESIS IMPLANTATION; RISK FACTOR; THROMBOEMBOLISM; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; BETA-ALANINE; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; GERMANY; HEMATOMA; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORPHOLINES; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; RISK FACTORS; THIOPHENES; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME;

EID: 84903934798     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut423     Document Type: Article

References (12)

1. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: Calendar year 2009 - A World Society of Arrhythmia's project. Pacing Clin Electrophysiol 2011;34:1013-27
2. Bernard ML, Shotwell M, Nietert PJ, Gold MR. Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. Circ Arrhythm Electrophysiol 2012;5:468-74
3. Tolosana JM, Berne P, Mont L, Heras M, Berruezo A, Monteagudo J et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thromboembolic events: Oral anticoagulation or bridging with intravenous hepariñ. A prospective randomized trial. Eur Heart J 2009;30:1880-4
4. Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 2013; 368:2084-93
5. RowleyCP, Bernard ML, BrabhamWW, Netzler PC, Sidney DS, Cuoco F et al. Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol 2013;111:1165-8
6. Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S et al. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: Results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation 2012;126:343-8
7. Turpie AG. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases. Arterioscler Thromb Vasc Biol 2007;27: 1238-47
8. Hermans C, Claeys D. Review of the rebound phenomenon in new anticoagulant treatments. Curr Med Res Opin 2006;22:471-81
9. Mantha S, Ansell J. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation. Thromb Haemost 2012;108:476-84
10. Jameson SS, Rymaszewska M, HuiAC, James P, Serrano-Pedraza I, Muller SD.Wound complications following rivaroxaban administration: A multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. J Bone Joint Surg Am 2012;94:1554-8
11. Jensen CD, Steval A, Partington PF, Reed MR, Muller SD. Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: A retrospective cohort study. J Bone Joint Surg Br 2011;93:91-5
12. Kaatz S, Douketis JD, Zhou H, Gage BF, White RH. Risk of stroke after surgery in patientswith and without chronic atrial fibrillation. J Thromb Haemost 2010;8:884-90